Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
Ana Camila Marques, Paulo Costa, Sérgia Velho, et al.
Journal of Controlled Release (2020) Vol. 320, pp. 180-200
Closed Access | Times Cited: 250

Showing 1-25 of 250 citing articles:

Nanomedicine in cancer therapy
Dahua Fan, Yongkai Cao, Meiqun Cao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 294
Nanoparticles in Clinical Translation for Cancer Therapy
Deepa Mundekkad, William C. Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1685-1685
Open Access | Times Cited: 184
Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
Xiangyi Kong, Yihang Qi, Xiangyu Wang, et al.
Progress in Materials Science (2023) Vol. 134, pp. 101070-101070
Closed Access | Times Cited: 86
Stimulus-responsive self-assembled prodrugs in cancer therapy
Xiao Dong, Rajeev Kungur Brahma, Chao Fang, et al.
Chemical Science (2022) Vol. 13, Iss. 15, pp. 4239-4269
Open Access | Times Cited: 84
The impact of protein corona on the biological behavior of targeting nanomedicines
Masoud Farshbaf, Hadi Valizadeh, Yunes Panahi, et al.
International Journal of Pharmaceutics (2022) Vol. 614, pp. 121458-121458
Closed Access | Times Cited: 72
Emerging ultrasmall luminescent nanoprobes for in vivo bioimaging
Shihua Li, Jing Wei, Qiaofeng Yao, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 5, pp. 1672-1696
Open Access | Times Cited: 68
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
Margaret M. Billingsley, Ningqiang Gong, Alvin J. Mukalel, et al.
Small (2023) Vol. 20, Iss. 11
Closed Access | Times Cited: 64
Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy
Ana Camila Marques, Paulo Costa, Sérgia Velho, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 216-216
Open Access | Times Cited: 48
Multifunctional nanoparticle for cancer therapy
Yan Gao, Kaiyu Wang, Jin Zhang, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 45
Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy
Shuxin Yan, Jintong Na, Xiyu Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 248-248
Open Access | Times Cited: 39
Precision-engineered metal and metal-oxide nanoparticles for biomedical imaging and healthcare applications
Thi Thuy Truong, Sudip Mondal, Vu Hoang Minh Doan, et al.
Advances in Colloid and Interface Science (2024) Vol. 332, pp. 103263-103263
Open Access | Times Cited: 37
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Mehregan Babamohamadi, Nastaran Keshavarz Mohammadi, Elham Faryadi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications
Dongdong Xu, Yang Li, Shouchun Yin, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 6, pp. 3167-3204
Open Access | Times Cited: 28
Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics
Yashaswi Dutta Gupta, Yuri Mackeyev, Sunil Krishnan, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Enhancing CAR Macrophage Efferocytosis Via Surface Engineered Lipid Nanoparticles Targeting LXR Signaling
Skylar T. Chuang, Joshua B. Stein, Sarah Nevins, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 22
EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta
Hannah C. Geisler, Aditi A Ghalsasi, Hannah C Safford, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 455-469
Closed Access | Times Cited: 17
Nanoparticle innovations in targeted cancer therapy: advancements in antibody–drug conjugates
Magdi T. Abdelhamid, Al-Hassan Soliman Wadan, Hosam A. Saad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 4
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
Salma Khan, Yeonjoo Choi, Mysore S. Veena, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation
Emmanuel Faderin, Terungwa H. Iorkula, Omowunmi Rebecca Aworinde, et al.
Medical Oncology (2025) Vol. 42, Iss. 2
Closed Access | Times Cited: 3
Control of biomedical nanoparticle distribution and drug release in vivo by complex particle design strategies
Melanie Bresinskya, Achim Goepfericha
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114634-114634
Open Access | Times Cited: 2
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles
Elias da Silva Santos, Karina Alexandre Barros Nogueira, Luiziana Cavalcante Costa Fernandes, et al.
International Journal of Pharmaceutics (2020) Vol. 592, pp. 120082-120082
Closed Access | Times Cited: 138
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
Sara Ponziani, Giulia Di Vittorio, Giuseppina Pitari, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5510-5510
Open Access | Times Cited: 130
An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
Alberto Juan, Francisco J. Cimas, Iván Bravo, et al.
Pharmaceutics (2020) Vol. 12, Iss. 9, pp. 802-802
Open Access | Times Cited: 89
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
Tina Briolay, Tacien Petithomme, Morgane Fouet, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 89
Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect
Alex N. Frickenstein, Jordan M. Hagood, Collin Britten, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 570-570
Open Access | Times Cited: 82
Page 1 - Next Page

Scroll to top